Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-10

Clinical Trial Update: Reduced-dose Conditioning Regimen Containing TBI in HSCT Treating Elderly Patients With Aplastic Anemia [Phase 2]

View source ↗

Summary

Phase 2 trial assessing a reduced-dose conditioning regimen that includes total body irradiation (TBI) for hematopoietic stem cell transplantation in elderly pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Aplastic Anaemia, HSCT | Phase 2 | Status: NOT_YET_RECRUITING